SMAD7 and diabetic kidney disease: Studies have shown that cinobufagin reduces the expression and phosphorylation of Smad2/3 in the TGFβ/Smad pathway, increases the expression of Smad7, and then reduces the expression of collagen IV, thereby slowing the occurrence of renal tissue fibrosis and preventing and treating diabetic nephropathy [11, 12].